Publication: Controlled human malaria infection with a clone of Plasmodium vivax with highquality genome assembly
4
Issued Date
2021-12-08
Resource Type
ISSN
23793708
Other identifier(s)
2-s2.0-85120879529
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
JCI Insight. Vol.6, No.23 (2021)
Suggested Citation
Angela M. Minassian, Yrene Themistocleous, Sarah E. Silk, Jordan R. Barrett, Alison Kemp, Doris Quinkert, Carolyn M. Nielsen, Nick J. Edwards, Thomas A. Rawlinson, Fernando Ramos Lopez, Wanlapa Roobsoong, Katherine J.D. Ellis, Jee Sun Cho, Eerik Aunin, Thomas D. Otto, Adam J. Reid, Florian A. Bach, Geneviève M.C. Labbé, Ian D. Poulton, Arianna Marini, Marija Zaric, Margaux Mulatier, Raquel Lopej Ramon, Megan Baker, Celia H. Mitton, Jason C. Sousa, Nattawan Rachaphaew, Chalermpon Kumpitak, Nongnuj Maneechai, Chayanut Suansomjit, Tianrat Piteekan, Mimi M. Hou, Baktash Khozoee, Kirsty McHugh, David J. Roberts, Alison M. Lawrie, Andrew M. Blagborough, Fay L. Nugent, Iona J. Taylor, Kimberly J. Johnson, Philip J. Spence, Jetsumon Sattabongkot, Sumi Biswas, Julian C. Rayner, Simon J. Draper Controlled human malaria infection with a clone of Plasmodium vivax with highquality genome assembly. JCI Insight. Vol.6, No.23 (2021). doi:10.1172/jci.insight.152465 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/77407
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Controlled human malaria infection with a clone of Plasmodium vivax with highquality genome assembly
Author(s)
Angela M. Minassian
Yrene Themistocleous
Sarah E. Silk
Jordan R. Barrett
Alison Kemp
Doris Quinkert
Carolyn M. Nielsen
Nick J. Edwards
Thomas A. Rawlinson
Fernando Ramos Lopez
Wanlapa Roobsoong
Katherine J.D. Ellis
Jee Sun Cho
Eerik Aunin
Thomas D. Otto
Adam J. Reid
Florian A. Bach
Geneviève M.C. Labbé
Ian D. Poulton
Arianna Marini
Marija Zaric
Margaux Mulatier
Raquel Lopej Ramon
Megan Baker
Celia H. Mitton
Jason C. Sousa
Nattawan Rachaphaew
Chalermpon Kumpitak
Nongnuj Maneechai
Chayanut Suansomjit
Tianrat Piteekan
Mimi M. Hou
Baktash Khozoee
Kirsty McHugh
David J. Roberts
Alison M. Lawrie
Andrew M. Blagborough
Fay L. Nugent
Iona J. Taylor
Kimberly J. Johnson
Philip J. Spence
Jetsumon Sattabongkot
Sumi Biswas
Julian C. Rayner
Simon J. Draper
Yrene Themistocleous
Sarah E. Silk
Jordan R. Barrett
Alison Kemp
Doris Quinkert
Carolyn M. Nielsen
Nick J. Edwards
Thomas A. Rawlinson
Fernando Ramos Lopez
Wanlapa Roobsoong
Katherine J.D. Ellis
Jee Sun Cho
Eerik Aunin
Thomas D. Otto
Adam J. Reid
Florian A. Bach
Geneviève M.C. Labbé
Ian D. Poulton
Arianna Marini
Marija Zaric
Margaux Mulatier
Raquel Lopej Ramon
Megan Baker
Celia H. Mitton
Jason C. Sousa
Nattawan Rachaphaew
Chalermpon Kumpitak
Nongnuj Maneechai
Chayanut Suansomjit
Tianrat Piteekan
Mimi M. Hou
Baktash Khozoee
Kirsty McHugh
David J. Roberts
Alison M. Lawrie
Andrew M. Blagborough
Fay L. Nugent
Iona J. Taylor
Kimberly J. Johnson
Philip J. Spence
Jetsumon Sattabongkot
Sumi Biswas
Julian C. Rayner
Simon J. Draper
Abstract
Controlled human malaria infection (CHMI) provides a highly informative means to investigate host-pathogen interactions and enable in vivo proof-of-concept efficacy testing of new drugs and vaccines. However, unlike Plasmodium falciparum, well-characterized P. vivax parasites that are safe and suitable for use in modern CHMI models are limited. Here, 2 healthy malaria-naive United Kingdom adults with universal donor blood group were safely infected with a clone of P. vivax from Thailand by mosquito-bite CHMI. Parasitemia developed in both volunteers, and prior to treatment, each volunteer donated blood to produce a cryopreserved stabilate of infected RBCs. Following stringent safety screening, the parasite stabilate from one of these donors (PvW1) was thawed and used to inoculate 6 healthy malaria-naive United Kingdom adults by blood-stage CHMI, at 3 different dilutions. Parasitemia developed in all volunteers, who were then successfully drug treated. PvW1 parasite DNA was isolated and sequenced to produce a high-quality genome assembly by using a hybrid assembly method. We analyzed leading vaccine candidate antigens and multigene families, including the vivax interspersed repeat (VIR) genes, of which we identified 1145 in the PvW1 genome. Our genomic analysis will guide future assessment of candidate vaccines and drugs, as well as experimental medicine studies.
